Using AI to diagnose birth defect in fetal ultrasound images
14 Jul 2022
In a new proof-of-concept study researchers are pioneering the use of a unique Artificial Intelligence-based deep learning model as an assistive tool for the rapid and accurate reading of ultrasound images.
In a new proof-of-concept study led by Dr. Mark Walker at the University of Ottawa's Faculty of Medicine, researchers are pioneering the use of a unique Artificial Intelligence-based deep learning model as an assistive tool for the rapid and accurate reading of ultrasound images.
The goal of the team's study was to demonstrate the potential for deep-learning architecture to support early and reliable identification of cystic hygroma from first trimester ultrasound scans. Cystic hygroma is an embryonic condition that causes the lymphatic vascular system to develop abnormally. It's a rare and potentially life-threatening disorder that leads to fluid swelling around the head and neck.
The birth defect can typically be easily diagnosed prenatally during an ultrasound appointment, but Dr. Walker -- co-founder of the OMNI Research Group (Obstetrics, Maternal and Newborn Investigations) at The Ottawa Hospital -- and his research group wanted to test how well AI-driven pattern recognition could do the job.
"What we demonstrated was in the field of ultrasound we're able to use the same tools for image classification and identification with a high sensitivity and specificity," says Dr. Walker, who believes their approach might be applied to other fetal anomalies generally identified by ultrasonography.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.